Mifepristone is safe, effective and widely accepted by providers and patients in the US. Yet it remains a prime target of the anti-abortion movement, including in the current politically motivated review at the FDA. A new analysis by Guttmacher experts Kelly Baden, Joerg Dreweke and Rachel Jones examines mifepristone’s exemplary safety record and escalating attacks rooted in junk science. Learn more: https://gu.tt/42VEcff #MedicationAbortion #ReproductiveHealth
Guttmacher Institute’s Post
More from this author
Explore content categories
- Career
- Productivity
- Finance
- Soft Skills & Emotional Intelligence
- Project Management
- Education
- Technology
- Leadership
- Ecommerce
- User Experience
- Recruitment & HR
- Customer Experience
- Real Estate
- Marketing
- Sales
- Retail & Merchandising
- Science
- Supply Chain Management
- Future Of Work
- Consulting
- Writing
- Economics
- Artificial Intelligence
- Employee Experience
- Workplace Trends
- Fundraising
- Networking
- Corporate Social Responsibility
- Negotiation
- Communication
- Engineering
- Hospitality & Tourism
- Business Strategy
- Change Management
- Organizational Culture
- Design
- Innovation
- Event Planning
- Training & Development
Critical insights. 👏 It’s alarming that despite clear evidence of safety, mifepristone continues to face politically motivated attacks. Protecting access is crucial for reproductive rights everywhere.